ClinVar Miner

Submissions for variant NM_000530.8(MPZ):c.292C>T (p.Arg98Cys) (rs121913590)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Athena Diagnostics Inc RCV000015238 SCV000255799 pathogenic Charcot-Marie-Tooth disease, demyelinating, type 1b 2013-11-06 criteria provided, single submitter clinical testing
GeneDx RCV000237048 SCV000292963 pathogenic not provided 2018-09-07 criteria provided, single submitter clinical testing The R98C pathogenic variant in the MPZ gene has been reported previously as a de novo finding in multiple unrelated individuals with MPZ-related disorders (Rouger et al., 1996; Baets et al., 2011). Functional studies suggest that R98C results in reduced transport of the MPZ protein to the plasma membrane (Lee et al., 2010; Saporta et al., 2012). The R98C variant is not observed in large population cohorts (Lek et al., 2016). The R98C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. Additionally, multiple pathogenic missense variants at this residue (R98H/P) have been reported in association with MPZ-related disorders (Rouger et al., 1996; Stenson et al., 2014). Therefore, the presence of R98C is consistent with the diagnosis of a MPZ-related disorder in this individual.
Invitae RCV000548074 SCV000636242 pathogenic Charcot-Marie-Tooth disease, type I 2020-02-19 criteria provided, single submitter clinical testing This sequence change replaces arginine with cysteine at codon 98 of the MPZ protein (p.Arg98Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is not present in population databases (rs121913590, ExAC no frequency). This variant has been reported in many individuals affected with Charcot-Marie-Tooth disease and Dejerine-Sottas syndrome (PMID: 9168174, 8644725, 20461396, 21840889, 8797476). In several of these individuals, it was shown to arise de novo (PMID: 9168174, 8644725, 8797476). ClinVar contains an entry for this variant (Variation ID: 14175). Experimental studies have shown that this missense change causes the retention of MPZ in the endoplasmic reticulum both in vitro and in vivo and recapitulates the Charcot-Marie-Tooth disease phenotype in mice (PMID: 22689911, 20461396). For these reasons, this variant has been classified as Pathogenic.
Baylor Genetics RCV000015238 SCV001521544 pathogenic Charcot-Marie-Tooth disease, demyelinating, type 1b 2020-05-21 criteria provided, single submitter clinical testing This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].
OMIM RCV000015238 SCV000035497 pathogenic Charcot-Marie-Tooth disease, demyelinating, type 1b 1996-03-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.